Lupin Expands Europe Access to YUVEZZI Presbyopia Therapy
Mumbai, India; Amsterdam, Netherlands; London, UK; Naples, Florida; Warren, New Jersey, August 20, 2026 Lupin Limited and Tenpoint Therapeutics...
Generative AI
Advertisement
HealthTab and Abbott Expand UK Point-of-Care Testing
Vancouver, British Columbia, August 20, 2026 Avricore Health Inc. has announced that its wholly owned subsidiary, HealthTab Ltd., has...
FDA Seeks Input on Generative AI Medical Device Rules
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
Kirin Advances AI-Native Research With GenerativeX
Tokyo, Japan, August 5, 2026 Kirin Holdings Co., Ltd. and GenerativeX Inc. have launched a new research model that...
Insilico Medicine Nominates AI-Designed ISM9077 as Preclinical Candidate for Ocular Diseases
HONG KONG, August 5, 2026 Insilico Medicine has announced the nomination of ISM9077 as its 32nd Preclinical Candidate (PCC)...
Advertisements
Hippocratic AI Launches Rapid Response Climate Agents for Healthcare
MENLO PARK, Calif., July 31, 2026 Hippocratic AI has launched a new suite of Rapid Response Climate Agents, enabling...
DifGen Wins FDA IND Clearance for Breast Cancer Therapy
Miramar, Fla., July 27, 2026 DifGen Pharmaceuticals LLC has announced that the U.S. Food and Drug Administration (FDA) has...
Insilico Medicine Presents ISM6331 Phase 1 Data at ESMO
Cambridge, MA, July 27, 2026 Insilico Medicine has announced that first-in-human Phase 1 clinical trial data for ISM6331, its...
Aqemia Broadens AI Drug Discovery Research with Sanofi
PARIS & LONDON, July 17, 2026 Aqemia, the biotechnology company pioneering physics-based generative artificial intelligence (AI) for drug discovery,...
Insilico Medicine Partners Bora for AI Drug Innovation
HONG KONG & TAIPEI, Taiwan, July 14, 2026 Insilico Medicine and Bora Pharmaceuticals Co., Ltd. have announced a landmark...
Advertisement
